The growth in the historic period can be attributed to increased global hepatitis a and b prevalence, expansion of travel medicine services, availability of combination vaccine formulations, inclusion in adult immunization schedules, rising occupational exposure prevention.
The growth in the forecast period can be attributed to increasing international travel volumes, expansion of adult vaccination programs, growing focus on preventive liver health, rising healthcare spending on vaccines, improved vaccine access through retail channels. Major trends in the forecast period include increasing adoption of combination hepatitis vaccines, rising demand from travel-related immunization, expansion of occupational health vaccination programs, growing preference for pre-filled syringe formulations, enhanced awareness of hepatitis prevention.
The rising incidence of hepatitis A is expected to drive the growth of the Twinrix market going forward. Hepatitis A is a viral infection affecting the liver, commonly transmitted through contaminated food or water, and causes symptoms such as jaundice, fatigue, and nausea. The increase in hepatitis A cases is attributed to poor sanitation, ingestion of contaminated food or water, and higher exposure in at-risk populations. Twinrix provides combined protection against both hepatitis A and B, reducing the risk of infection and supporting preventive healthcare. For instance, in April 2025, according to the UK Health Security Agency, hepatitis A infections in the UK usually average around 400 cases annually, but in 2024, cases exceeded 800. Therefore, the rising prevalence of hepatitis A and B infections is driving growth in the Twinrix market.
The growth in travel and tourism is expected to propel the Twinrix market. Travel and tourism involve the movement of people for leisure, business, or other purposes, supported by transportation, accommodation, and related services. The increase in travel is fueled by global connectivity, rising disposable incomes, and improved travel services, resulting in more frequent international trips and broader exposure to infectious diseases. Twinrix supports travelers by providing combined protection against hepatitis A and B, reducing the risk of infection and ensuring safer travel. For instance, in May 2024, the UK Office for National Statistics reported that UK residents undertook 6.3 million international business trips in 2023, up from 4.9 million in 2022. Therefore, the rise in travel and tourism is driving growth in the Twinrix market.
The increasing awareness of vaccination is expected to drive the growth of the Twinrix market. Vaccination stimulates the immune system to develop protection against specific infectious diseases, preventing outbreaks and reducing disease burden. Awareness is rising due to public health campaigns, educational programs, trusted healthcare advice, media influence, and dissemination of scientific evidence supporting vaccine safety and effectiveness. Greater awareness promotes the adoption of Twinrix by highlighting the risks of hepatitis A and B, encouraging preventive measures, and increasing vaccine uptake. For instance, in July 2025, according to the World Health Organization, global DTP3 vaccine coverage reached 85% in 2024, while first-dose HPV coverage in girls increased from 27% in 2023 to 31% in 2024, reflecting improved immunization efforts. Therefore, increasing awareness of vaccination is driving growth in the Twinrix market.
Major companies operating in the twinrix market are GlaxoSmithKline plc.
North America was the largest region in the twinrix market in 2025. The regions covered in the twinrix market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the twinrix market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.
Tariffs are influencing the twinrix market by increasing costs of imported vaccine components, adjuvants, sterile syringes, and cold-chain distribution infrastructure. Europe and North America are most affected due to reliance on international vaccine supply chains, while developing regions face higher costs for combination vaccines. These tariffs contribute to elevated manufacturing and distribution expenses. However, they are also driving regional vaccine production investments, localized packaging operations, and stronger domestic supply capabilities for combination immunizations.
The twinrix market research report is one of a series of new reports that provides twinrix market statistics, including twinrix industry global market size, regional shares, competitors with a twinrix market share, detailed twinrix market segments, market trends and opportunities, and any further data you may need to thrive in the twinrix industry. This twinrix market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Twinrix is a combination vaccine designed to protect against both hepatitis A and hepatitis B infections. It is commonly recommended for individuals at risk, including travelers to areas where these infections are prevalent, healthcare workers, and others in high-exposure settings.
The main indications for Twinrix are hepatitis A, hepatitis B, and combined immunization. Hepatitis A is a viral liver infection transmitted through contaminated food, water, or close contact with an infected person, while hepatitis B is transmitted through blood and bodily fluids. Twinrix is available in intramuscular injection and pre-filled syringe formulations, including monovalent and combination vaccine options. It is distributed through hospital pharmacies, retail pharmacies, and online pharmacies, and is used by pediatric, adult, and geriatric populations.
The twinrix market consists of sales of standard-dose, accelerated-dose, vials and combination syringe. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The growth in the forecast period can be attributed to increasing international travel volumes, expansion of adult vaccination programs, growing focus on preventive liver health, rising healthcare spending on vaccines, improved vaccine access through retail channels. Major trends in the forecast period include increasing adoption of combination hepatitis vaccines, rising demand from travel-related immunization, expansion of occupational health vaccination programs, growing preference for pre-filled syringe formulations, enhanced awareness of hepatitis prevention.
The rising incidence of hepatitis A is expected to drive the growth of the Twinrix market going forward. Hepatitis A is a viral infection affecting the liver, commonly transmitted through contaminated food or water, and causes symptoms such as jaundice, fatigue, and nausea. The increase in hepatitis A cases is attributed to poor sanitation, ingestion of contaminated food or water, and higher exposure in at-risk populations. Twinrix provides combined protection against both hepatitis A and B, reducing the risk of infection and supporting preventive healthcare. For instance, in April 2025, according to the UK Health Security Agency, hepatitis A infections in the UK usually average around 400 cases annually, but in 2024, cases exceeded 800. Therefore, the rising prevalence of hepatitis A and B infections is driving growth in the Twinrix market.
The growth in travel and tourism is expected to propel the Twinrix market. Travel and tourism involve the movement of people for leisure, business, or other purposes, supported by transportation, accommodation, and related services. The increase in travel is fueled by global connectivity, rising disposable incomes, and improved travel services, resulting in more frequent international trips and broader exposure to infectious diseases. Twinrix supports travelers by providing combined protection against hepatitis A and B, reducing the risk of infection and ensuring safer travel. For instance, in May 2024, the UK Office for National Statistics reported that UK residents undertook 6.3 million international business trips in 2023, up from 4.9 million in 2022. Therefore, the rise in travel and tourism is driving growth in the Twinrix market.
The increasing awareness of vaccination is expected to drive the growth of the Twinrix market. Vaccination stimulates the immune system to develop protection against specific infectious diseases, preventing outbreaks and reducing disease burden. Awareness is rising due to public health campaigns, educational programs, trusted healthcare advice, media influence, and dissemination of scientific evidence supporting vaccine safety and effectiveness. Greater awareness promotes the adoption of Twinrix by highlighting the risks of hepatitis A and B, encouraging preventive measures, and increasing vaccine uptake. For instance, in July 2025, according to the World Health Organization, global DTP3 vaccine coverage reached 85% in 2024, while first-dose HPV coverage in girls increased from 27% in 2023 to 31% in 2024, reflecting improved immunization efforts. Therefore, increasing awareness of vaccination is driving growth in the Twinrix market.
Major companies operating in the twinrix market are GlaxoSmithKline plc.
North America was the largest region in the twinrix market in 2025. The regions covered in the twinrix market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the twinrix market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.
Tariffs are influencing the twinrix market by increasing costs of imported vaccine components, adjuvants, sterile syringes, and cold-chain distribution infrastructure. Europe and North America are most affected due to reliance on international vaccine supply chains, while developing regions face higher costs for combination vaccines. These tariffs contribute to elevated manufacturing and distribution expenses. However, they are also driving regional vaccine production investments, localized packaging operations, and stronger domestic supply capabilities for combination immunizations.
The twinrix market research report is one of a series of new reports that provides twinrix market statistics, including twinrix industry global market size, regional shares, competitors with a twinrix market share, detailed twinrix market segments, market trends and opportunities, and any further data you may need to thrive in the twinrix industry. This twinrix market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Twinrix is a combination vaccine designed to protect against both hepatitis A and hepatitis B infections. It is commonly recommended for individuals at risk, including travelers to areas where these infections are prevalent, healthcare workers, and others in high-exposure settings.
The main indications for Twinrix are hepatitis A, hepatitis B, and combined immunization. Hepatitis A is a viral liver infection transmitted through contaminated food, water, or close contact with an infected person, while hepatitis B is transmitted through blood and bodily fluids. Twinrix is available in intramuscular injection and pre-filled syringe formulations, including monovalent and combination vaccine options. It is distributed through hospital pharmacies, retail pharmacies, and online pharmacies, and is used by pediatric, adult, and geriatric populations.
The twinrix market consists of sales of standard-dose, accelerated-dose, vials and combination syringe. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Twinrix Market Characteristics
3. Twinrix Market Supply Chain Analysis
4. Global Twinrix Market Trends and Strategies
5. Twinrix Market Analysis of End Use Industries
7. Global Twinrix Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Twinrix Total Addressable Market (TAM) Analysis for the Market
9. Twinrix Market Segmentation
10. Twinrix Market Regional and Country Analysis
11. Asia-Pacific Twinrix Market
12. China Twinrix Market
13. India Twinrix Market
14. Japan Twinrix Market
15. Australia Twinrix Market
16. South Korea Twinrix Market
17. Western Europe Twinrix Market
18. UK Twinrix Market
19. Germany Twinrix Market
20. France Twinrix Market
21. Eastern Europe Twinrix Market
22. North America Twinrix Market
23. USA Twinrix Market
24. Canada Twinrix Market
25. South America Twinrix Market
26. Middle East Twinrix Market
27. Africa Twinrix Market
29. Twinrix Market Competitive Landscape and Company Profiles
32. Twinrix Market High Potential Countries, Segments and Strategies
33. Appendix
Executive Summary
Twinrix Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses twinrix market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for twinrix? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The twinrix market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Indication: Hepatitis A; Hepatitis B; Combined Immunization2) By Formulation: Intramuscular Injection; Pre-Filled Syringes
3) By Composition: Monovalent Vaccines; Combination Vaccines
4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
5) By End User: Adult; Pediatric; Geriatric
Companies Mentioned: GlaxoSmithKline plc
Countries: Australia; India; China; South Korea; Japan; UK; France; Germany; USA; Canada.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Twinrix market report include:- GlaxoSmithKline plc
